DCM Shriram Fine Chemicals accepts resignation of independent director Behara
- Venkata Rama Subbu Behara resigned as independent director effective September 8, 2026
- Departure attributed to recent changes in the board structure
- Resignation filed under Regulation 30 of SEBI LODR Regulations, 2015
- Behara retains directorships at MTAR Technologies and Gabriel India

*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals accepted the resignation of Venkata Rama Subbu Behara as an independent director effective September 8, 2026. The departure follows recent changes in the company’s board structure.
The resignation was formalized through a letter dated September 8, 2026, submitted to Ms. Urvashi Tilak Dhar. Behara confirmed there are no other material reasons for his exit beyond the structural adjustments mentioned in his resignation letter.
Regulatory Compliance
The company disclosed the change pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Kokila Arora, Company Secretary and Compliance Officer, signed the intimation filed with both the BSE and NSE on September 9, 2026.
Director Profile
Behara continues to hold directorships in other listed entities. His current roles include:
- MTAR Technologies Limited: Member of the Audit Committee, Chairman of the Stakeholders' Relationship Committee, Member of the Nomination and Remuneration Committee, and Chairman of the Risk Management Committee.
- Gabriel India Limited: Member of the Stakeholders' Relationship Committee and the Nomination and Remuneration Committee.
Historical Stock Returns for DCM Shriram Fine Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.31% | +1.23% | +5.18% | -9.16% | 0.0% | 0.0% |
Who has been nominated as the replacement independent director for Venkata Rama Subbu Behara, and when is their appointment expected to be finalized?
How might this board restructuring impact DCM Shriram Fine Chemicals' strategic decision-making and governance oversight in the near term?
Given Behara's extensive committee roles at MTAR Technologies, will his departure from DCM Shriram affect his capacity to serve on those boards?


































